Shareholders' (Deficit) / Equity - Additional Information (Details) $ / shares in Units, € in Thousands, $ in Thousands |
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oct. 31, 2020
$ / shares
shares
|
Oct. 27, 2020
USD ($)
$ / shares
shares
|
Jul. 02, 2020
$ / shares
shares
|
Jun. 05, 2020
$ / shares
shares
|
Jun. 03, 2020
USD ($)
$ / shares
shares
|
Feb. 16, 2018
USD ($)
$ / shares
shares
|
May 18, 2017
USD ($)
$ / shares
shares
|
Dec. 16, 2016
USD ($)
$ / shares
shares
|
Nov. 18, 2015
USD ($)
$ / shares
shares
|
Jun. 30, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
Vote
$ / shares
shares
|
Dec. 31, 2018 |
Jun. 10, 2020
shares
|
Dec. 31, 2019
$ / shares
shares
|
Oct. 31, 2019
shares
|
Sep. 30, 2019
USD ($)
shares
|
Sep. 30, 2019
EUR (€)
shares
|
Aug. 19, 2019
USD ($)
shares
|
Aug. 19, 2019
EUR (€)
shares
|
Jul. 15, 2019
USD ($)
shares
|
Jul. 15, 2019
EUR (€)
shares
|
Dec. 14, 2018
USD ($)
shares
|
Dec. 14, 2018
EUR (€)
shares
|
May 30, 2018
$ / shares
shares
|
May 29, 2018
shares
|
May 15, 2018
$ / shares
|
Apr. 27, 2018
$ / shares
shares
|
Mar. 13, 2018
$ / shares
shares
|
Mar. 12, 2018
$ / shares
|
Feb. 15, 2018
shares
|
Dec. 09, 2016
$ / shares
shares
|
Oct. 14, 2015
$ / shares
shares
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares authorized |
|
|
|
|
|
44,557,606
|
7,956,715
|
|
3,659,453
|
|
150,000,000
|
|
100,000,000
|
50,000,000
|
|
|
|
|
|
|
|
|
|
50,000,000
|
|
|
|
44,557,606
|
|
|
|
413,110
|
Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
|
49,431,028
|
|
|
14,868,973
|
|
|
|
|
|
|
|
|
|
|
|
|
|
413,110
|
|
|
|
413,110
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
$ 0.01
|
$ 0.01
|
|
$ 0.01
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
$ 0.001
|
$ 0.0001
|
|
|
$ 0.01
|
Share consolidation basis nominal value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01571
|
|
|
|
|
|
|
Share consolidation basis, Renominalisation value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
|
|
|
Increase in common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,442,394
|
|
|
|
|
36,600,891
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
$ 32,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of vote per common share | Vote |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock rights and preferences |
|
|
|
|
|
|
|
|
|
|
The holders of ordinary shares have no preemptive or other subscription rights, and there are no redemption or sinking fund provisions with respect to such shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares, authorized |
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares issued |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, conversion basis |
|
|
|
|
|
|
|
|
|
|
|
one-for-one
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series B Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,801,493
|
|
|
|
|
Temporary equity, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
0.0001
|
|
|
|
Temporary equity, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,363,856
|
|
|
|
|
Undesignated Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares, authorized |
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares issued |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share consolidation basis nominal value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01571
|
|
|
|
|
|
|
Share consolidation basis, Renominalisation value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
|
|
|
Temporary equity, shares authorized |
|
|
|
|
|
|
|
|
3,022,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,032,463
|
|
|
9,548
|
|
Temporary equity, par value | $ / shares |
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
$ 0.0001
|
|
$ 0.01
|
|
Temporary equity, shares issued |
|
|
|
|
|
|
|
1,518,137
|
1,514,320
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,032,457
|
|
|
|
|
Temporary equity shares price per share | $ / shares |
|
|
|
|
|
|
|
$ 15.71
|
$ 15.71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross cash proceeds from Issuance of convertible preferred stock | $ |
|
|
|
|
|
|
|
$ 20,851
|
$ 20,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Convertible Preferred Shares | Founders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of debt amount | $ |
|
|
|
|
|
|
|
|
$ 90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock issued upon conversion |
|
|
|
|
|
|
|
|
5,728
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series B-1 Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share consolidation basis nominal value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01571
|
|
|
|
|
|
|
Share consolidation basis, Renominalisation value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
Temporary equity, shares authorized |
|
|
|
|
|
|
2,654,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, par value | $ / shares |
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, shares issued |
|
|
|
|
|
|
2,654,206
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity shares price per share | $ / shares |
|
|
|
|
|
|
$ 17.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross cash proceeds from Issuance of convertible preferred stock | $ |
|
|
|
|
|
|
$ 45,867
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series B-2 Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, shares authorized |
|
|
|
|
|
2,147,278
|
1,042,728
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, par value | $ / shares |
|
|
|
|
|
$ 0.01
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, shares issued |
|
|
|
|
|
1,709,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity shares price per share | $ / shares |
|
|
|
|
|
$ 18.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross cash proceeds from Issuance of convertible preferred stock | $ |
|
|
|
|
|
$ 32,230
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Silicon Valley Bank and Life Sciences Fund II LLC | Series B Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
|
19,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,890
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 18.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18.85
|
|
|
|
|
|
Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
|
19,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,890
|
|
|
|
|
|
June 3 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer License Agreement | Series A Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, shares issued |
|
|
|
|
|
|
|
|
190,961
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, additional shares issued |
|
|
|
|
|
|
|
190,961
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 3 Offering | June 3 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
2,971,770
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
$ 1.6825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
|
|
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
$ 4,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants closing date |
|
|
|
|
Jun. 05, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30 Offering | June 30 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
3,372,686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 1.4825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
|
|
|
|
|
|
|
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
$ 4,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants closing date |
|
|
|
|
|
|
|
|
|
Jul. 02, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
15,511,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
$ 0.01
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
$ 17,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
$ 15,500
|
|
|
|
|
|
|
|
|
$ 900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
1,884,615
|
|
|
|
|
|
|
|
|
|
1,268,859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
$ 0.8125
|
$ 0.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
Oct. 22, 2025
|
Oct. 27, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October Offering | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
20,192,307
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October Offering | Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
$ 110
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
11,411,539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
$ 0.64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October Offering | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
$ 0.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
20,192,307
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
$ 0.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Securities Purchase Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
208,023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
$ 2.1031
|
$ 1.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
|
|
|
Jun. 03, 2025
|
Dec. 05, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Securities Purchase Agreement | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
1,485,885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | June 30 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
236,088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
$ 1.8531
|
|
|
|
|
|
|
$ 1.42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
|
|
Jun. 30, 2025
|
|
|
|
|
|
|
Jan. 02, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | June 30 SPA | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
1,686,343
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | June 3 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants closing date |
|
|
|
|
Jun. 05, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
208,023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
$ 2.1031
|
$ 1.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
|
|
|
Jun. 03, 2025
|
Dec. 05, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | June 3 SPA | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
1,485,885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplier |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, maximum shares authorized for subscription |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
700,000
|
700,000
|
|
|
|
|
|
|
|
|
|
Maximum subscription units to be accepted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
199,056
|
199,056
|
245,493
|
245,493
|
17,222
|
17,222
|
190,615
|
190,615
|
|
|
|
|
|
|
|
|
|
Issuance of ordinary shares under subscription agreement | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,260
|
|
$ 1,670
|
|
$ 110
|
|
$ 1,360
|
|
|
|
|
|
|
|
|
|
|
Payment receivable upon common stock subscription agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,260
|
€ 1,150
|
$ 1,670
|
€ 1,500
|
$ 110
|
€ 100
|
$ 1,360
|
€ 1,200
|
|
|
|
|
|
|
|
|
|